CDTX vs PCG · rev $1.3M vs P/E 13, $37.68B cap
Cidara Therapeutics Inc (CDTX) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
PCG does not have a complete income-statement cache yet.
CDTX currently screens at market cap $6.96B. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the CDTX and PCG stock pages for the full models.
Not investment advice.